Hypermutability and silent mutations in human carcinogenesis

Seminars in Cancer Biology

Volumn 8, Issue 6, 1998, Pages 431-438

  Strauss, Bernard S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Mismatch repair; Silent mutation; Somatic hypermutability; TP53; Tumors

Indexed keywords

NUCLEOTIDE; PROTEIN P53;

CARCINOGENESIS; CODON; DATA BASE; GENE MUTATION; HUMAN; MUTATION RATE; POINT MUTATION; REVIEW; SILENT GENE; SOMATIC MUTATION;

EID: 0031987278     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1998.0092     Document Type: Article

References (51)

1. 1. Tomlinson IP, Novelli MR, Bodmer WF (1996) The mutation rate and cancer. Proc Natl Acad Sci USA 93:14800-14803
2. 2. Zuckerkandl E (1997) Neutral and nonneutra mutations: the creative mix-evolution of complexity in gene interaction systems. J Mol Evol 44(4):470
3. 3. Jackson AL, Loeb LA (1998) The mutation rate and cancer. Genetics 148:1483-1490
4. 4. Hall IJ, Gioeli D, Weissman BE, Tlsty TD (1997) Identification of additional complementation groups that regulate genomic instability. Genes Chromosomes Cancer 20:103-112
5. 5. Shiloh Y (1997) Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet 31:635-662
6. 6. Ohzeki S, Tachibana A, Tatsumi K, Kato T (1997) Spectra of spontaneous mutations at the hprt locus in colorectal carcinoma cell lines defective in mismatch repair. Carcinogenesis 18:1127-1133
7. 7. Losi L, Fante R, Di Gregorio C, Aisoni ML, Lanza G, Maestri I et al (1995) Biologic characterization of hereditary non-polyposis colorectal cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. Am J Clin Pathol 103:265-270
8. 8. Muleris M, Dutrillaux AM, Olschwang S, Salmon RJ, Dutrillaux B (1995) Predominance of normal karyotype in colorectal tumors from hereditary non-polyposis colorectal cancer patients. Genes Chromosomes Cancer 14:223-226
9. 9. Loeb LA (1998) Cancer cells exhibit a mutator phenotype. Adv Cancer Res 72:25-56
10. 10. Simpson AJ (1997) The natural somatic mutation frequency and human carcinogenesis. Adv Cancer Res 71:209-240
11. 11. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H et al (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808-811
12. 12. Homfray TF, Cottrell SE, Ilyas M, Rowan A, Talbot IC, Bodmer WF et al (1998) Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours. Hum Mutat 11:114-120
13. 13. Meuth M (1996) Patterns of mutation in cancer cells. Cancer Surv 28:33-46
14. 14. Strauss BS (1998) Hypermutability in carcinogenesis. Genetics 148:1619-1926
15. 15. Wittenkeller JL, Storer B, Bittner G, Schiller JH (1997) Comparison of spontaneous and induced mutation rates in an immortalized human bronchial epithelial cell line and its tumorigenic derivative. Oncology 54:335-341
16. 16. Strauss BS (1997) Silent and multiple mutations in p53 and the question of the hypermutability of tumors. Carcinogenesis 18:1445-1452
17. 17. Hurst LD, Ellegren H (1998). Sex biases in the mutation rate. Trends Genet 14:446-452
18. 18. Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, Galli M et al (1995) Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res 55:2665-2672
19. 19. Comeron J, Kreitman M (1998) The correlation between synonymous and nonsynonymous substitutions in Drosophila: selection or relaxed constraints? Genetics 150:767-775
20. 20. Sharp PM, Averof M, Lloyd AT, G M, Peden JF (1995) DNA sequence evolution: the sounds of silence. Phil Trans R Soc London B 349:241-247
21. 21. Sharp PM, Stenico M, Peden JF, Lloyd AT (1993) Codon usage: mutational bias, translational selection, or both? Biochem Soc Trans 21:835-841
22. 22. Zietkiewicz E, Yotova V, Jarnik M, Korab-Laskowska M, Kidd KK, Modiano D et al (1998) Genetic structure of the ancestral population of modern humans. J Mol Evol 47:146-155
23. 23. Li W-H, Sadler LA (1991) Low nucleotide diversity in man. Genetics 129:513-523
24. 24. Rodin SN, Holmquist GP, Rodin AS (1998) CpG transition strand asymmetry and hitch-hiking mutations as measures of tumorigenic selection in shaping the p53 mutational spectrum. Int J Mol Med 1:191-199
25. 25. Rodin SN, Rodin AS (1998) Strand asymmetry of CpG transitions as indicator of G1 phase-dependent origin of multiple tumorigenic p53 mutations in stem cells. Proc Natl Acad Sci USA 95:11927-11932
26. 26. Hainaut P, Hollstein, M (1999) p53 and human cancer: the first ten thousand mutations. Adv Cancer Res, in press
27. 27. Evan G, Littlewood T (1998) A matter of life and cell death. Science 281:1317-1322
28. 28. Weston A, Godbold JH (1997) Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis. Environ Health Perspect 105(Suppl 4):919-926.
29. 29. Taylor JA, Li Y, He M, Mason T, Mettlin C, Vogler WJ et al (1996) p53 mutations in bladder tumors from arylamine-exposed workers. Cancer Res 56:294-298
30. 30. Dorner T, Brezinschek HP, Foster SJ, Brezinschek RI, Farner NL, Lipsky PE (1998) Delineation of selective influences shaping the mutated expressed human Ig heavy chain repertoire. J Immunol 160:2831-2841
31. 31. Aguilar F, Harris CC, Sun T, Hollstein M, Cerutti P (1994) Geographic variation of p53 mutational profile in nonmalignant human liver. Science 264:1317-1319
32. 32. Martin GM, Ogburn CE, Colgin LM, Gown AM, Edland SD, Monnat RJ, Jr (1996) Somatic mutations are frequent and increase with age in human kidney epithelial cells. Hum Mol Genet 5:215-221
33. 33. Arzimanoglou II, Gilbert F, Barber HR (1998) Microsatellite instability in human solid tumors. Cancer 82:1808-1820
34. 34. Karnik P, Plummer S, Casey G, Myles J, Tubbs R, Crowe J et al (1998) Microsatellite instability at a single locus (D11S988) on chromosome 11p15.5 as a late event in mammary tumorigenesis. Hum Mol Genet 19954:1889-1894
35. 35. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141-196
36. 36. Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S et al (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 95:8698-8702
37. 37. Hussain SP, Harris CC (1998) Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 58:4023-4037
38. 38. Laurent-Puig P, Beroud C, Soussi T (1998) APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 26:269-270
39. 39. Shen HM, Peters A, Baron B, Zhu X, Storb U (1998) Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280:1750-1752
40. 40. Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L et al (1998) BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 95:11816-11821
41. 41. Storb U (1996) Molecular mechanism of somatic hypermutation of immunoglobulin genes. Curr Opin Immunol 8:206-214
42. 42. Schaaper RM (1993) Base selection, proofreading, and mismatch repair during DNA replication in Escherichia coli. J Biol Chem 268:23762-23765
43. 43. Strauss BS (1992) The origin of point mutations in human tumor cells. Cancer Res 52:249-253
44. 44. Richards B, Zhang H, Phear G, Meuth M (1997) Conditional mutator phenotypes in hMSH2-deficient tumor cell lines Science 277:1523-1526
45. 45. Cairns J, Foster PL (1991) Adaptive reversion of a frameshift mutation in Escherichia coli. Genetics 128:695-701
46. 46. Foster PL (1998) Adaptive mutation: has the unicorn landed? Genetics 148:1453-1459
47. 47. Harris RS, Feng G, Ross KJ, Sidhu R, Thulin C, Longerich S et al (1997) Mismatch repair protein MutL becomes limiting during stationary-phase mutation. Genes Dev 11:2426-2437
48. 48. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ et al (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58:3455-3460
49. 49. Ninio J (1991) Transient mutators: a semiquantitative analysis of the influence of translation and transcription errors on mutation rates. Genetics 129:957-962
50. 50. Lengauer C, Kinzler KW, Vogelstein B (1997) DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci USA 94:2545-2550
51. 51. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M et al (1998) IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res 26:205-213